91±¬ÁÏ

May 2

A common killer bug is endangering Americans: ‘Pandemic in plain sight’

Streptococcus Group A affects close to 20% of U.S. children, according to Dr. Joshua Osowicki, senior research fellow at the Murdoch Children’s Research Institute in Australia.

May 1

Weight-loss drugs to get surprising endorsement from global health giant

The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity epidemic, according to Reuters.

May 1

Gender dysphoria treatments pose ‘significant risks’ to kids and teens, HHS report reveals

The U.S. Department of Health and Human Services (HHS) on Thursday released a comprehensive review of best practices for children and teens with gender dysphoria.

April 28

‘Abortion pill’ found to have ‘severe adverse effects’ for 1 in 10 women, study finds

A new study reveals "serious adverse events" associated with mifepristone, commonly called the "abortion pill," as researchers and experts highlight potential risks.

April 28

Alternative cancer treatment could replace chemo and surgery, study suggests

A "groundbreaking" cancer treatment trial by Memorial Sloan Kettering shows immunotherapy alone can eliminate some tumors, offering patients an alternative to chemotherapy and surgery.

April 26

RFK Jr. urges Americans to dispose of medicine safely — and to not flush them

On National Prescription Drug Take Back Day, HHS Secretary Robert F. Kennedy Jr. is urging Americans to dispose of their prescription medications safely.

April 22

Stem-cell therapy for Parkinson's shows 'strong promise' in relieving symptoms

In a small study, researchers transplanted stem cells into the brains of 12 Parkinson’s patients, stopping progression and bringing about improvement in motor function.

April 18

New drug for Parkinson’s shown to be effective in clinical trials: 'Very encouraged'

A new pill, tavapadon, has shown potential in easing Parkinson’s symptoms while limiting side effects. In patients taking at least 400 mg of levodopa daily, tavapadon helped reduce motor fluctuations.

April 17

First GLP-1 pill for weight loss, diabetes shows success in late-phase trial

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type 2 diabetes. Previous versions were administered via injection.

April 16

Fake Ozempic drugs found in US drug supply, FDA warns

The FDA has issued a warning about counterfeit Ozempic medications, sharing the lot numbers and serial numbers of products that should not be used, sold or distributed.